These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36344452)

  • 1. Biomimetic Nanoplatelets to Target Delivery Hirudin for Site-Specific Photothermal/Photodynamic Thrombolysis and Preventing Venous Thrombus Formation.
    Li S; Zhang K; Ma Z; Zhang W; Song Z; Wang W; Han H
    Small; 2022 Dec; 18(51):e2203184. PubMed ID: 36344452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic Platelet Nanomotors for Site-Specific Thrombolysis and Ischemic Injury Alleviation.
    Chen YT; Liu CH; Pan WY; Jheng PR; Hsieh YSY; Burnouf T; Fan YJ; Chiang CC; Chen TY; Chuang EY
    ACS Appl Mater Interfaces; 2023 Jul; 15(27):32967-32983. PubMed ID: 37384742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-Organic-Framework-Derived Carbon Nanostructures for Site-Specific Dual-Modality Photothermal/Photodynamic Thrombus Therapy.
    Zhang F; Liu Y; Lei J; Wang S; Ji X; Liu H; Yang Q
    Adv Sci (Weinh); 2019 Sep; 6(17):1901378. PubMed ID: 31508294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent.
    Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL
    Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy.
    Zhao Z; Li X; Wang Y; Liu C; Ling G; Zhang P
    J Nanobiotechnology; 2023 Nov; 21(1):439. PubMed ID: 37990207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological Mediator-Propelled Nanosweeper for Nonpharmaceutical Thrombus Therapy.
    Deng Q; Zhang L; Lv W; Liu X; Ren J; Qu X
    ACS Nano; 2021 Apr; 15(4):6604-6613. PubMed ID: 33724000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does antithrombotic therapy influence residual thrombus after thrombolysis of platelet-rich thrombus? Effects of recombinant hirudin, heparin, or aspirin.
    Mruk JS; Zoldhelyi P; Webster MW; Heras M; Grill DE; Holmes DR; Fuster V; Chesebro JH
    Circulation; 1996 Feb; 93(4):792-9. PubMed ID: 8641009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection.
    Yu W; Yin N; Yang Y; Xuan C; Liu X; Liu W; Zhang Z; Zhang K; Liu J; Shi J
    Acta Biomater; 2022 Mar; 140():625-640. PubMed ID: 34902617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elaborately Engineering a Self-Indicating Dual-Drug Nanoassembly for Site-Specific Photothermal-Potentiated Thrombus Penetration and Thrombolysis.
    Zhao Z; Zhang X; Zhang H; Shan X; Bai M; Wang Z; Yang F; Zhang H; Kan Q; Sun B; Sun J; He Z; Luo C
    Adv Sci (Weinh); 2022 Feb; 9(4):e2104264. PubMed ID: 34802198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.
    Reilly MP; Weiss R; Askenase A; Tuite C; Soulen M; Mohler ER
    Vasc Med; 2000; 5(4):239-42. PubMed ID: 11213236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-Targeting Glycol Chitosan/Heparin-Decorated Polypyrrole Nanoparticle for Augmented Photothermal Thrombolytic Therapy.
    Lu TY; Chiang CY; Fan YJ; Jheng PR; Quiñones ED; Liu KT; Kuo SH; Hsieh HY; Tseng CL; Yu J; Chuang EY
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):10287-10300. PubMed ID: 33615773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen binding to activated platelets and its biomimetic thrombus-targeted thrombolytic strategies.
    Huang Y; Wang J; Guo Y; Shen L; Li Y
    Int J Biol Macromol; 2024 Aug; 274(Pt 1):133286. PubMed ID: 38908635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-Covered Nanocarriers for Targeted Delivery of Hirudin to Eliminate Thrombotic Complication in Tumor Therapy.
    Zhang K; Ma Z; Li S; Zhang W; Foda MF; Zhao Y; Han H
    ACS Nano; 2022 Nov; 16(11):18483-18496. PubMed ID: 36350264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered Nanoplatelets for Targeted Delivery of Plasminogen Activators to Reverse Thrombus in Multiple Mouse Thrombosis Models.
    Xu J; Zhang Y; Xu J; Liu G; Di C; Zhao X; Li X; Li Y; Pang N; Yang C; Li Y; Li B; Lu Z; Wang M; Dai K; Yan R; Li S; Nie G
    Adv Mater; 2020 Jan; 32(4):e1905145. PubMed ID: 31788896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute superior mesenteric venous thrombosis: transcatheter thrombolysis and aspiration thrombectomy therapy by combined route of superior mesenteric vein and artery in eight patients.
    Yang S; Liu B; Ding W; He C; Wu X; Li J
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):88-99. PubMed ID: 24934733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of paediatric deep venous thrombolysis.
    Taha MA; Busuttil A; Bootun R; Davies AH
    Phlebology; 2019 Apr; 34(3):179-190. PubMed ID: 29860923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catheter-directed thrombolysis of iliofemoral venous thrombosis].
    Ly B; Njaastad AM; Sandbaek G; Solstrand R; Rosales A; Slagsvold CE
    Tidsskr Nor Laegeforen; 2004 Feb; 124(4):478-80. PubMed ID: 14983192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Biomimicking and Multiarm Self-Indicating Nanoassembly for Site-Specific Photothermal-Potentiated Thrombolysis Assessed in Microfluidic and In Vivo Models.
    Liu KT; Quiñones ED; Liu MH; Lin CW; Chen YT; Chiang CC; Wu KC; Fan YJ; Chuang EY; Yu J
    Adv Healthc Mater; 2023 Sep; 12(24):e2300682. PubMed ID: 37289540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bolus thrombolysis in venous thromboembolism.
    Agnelli G; Parise P
    Chest; 1992 Apr; 101(4 Suppl):172S-182S. PubMed ID: 1555482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin.
    Meyer BJ; Badimon JJ; Chesebro JH; Fallon JT; Fuster V; Badimon L
    Circulation; 1998 Feb; 97(7):681-5. PubMed ID: 9495304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.